Glenmark launches COVID-19 drug in India

Glenmark Pharmaceuticals on Saturday launched antiviral drug Favipiravir for treatment of mild-to-moderate Covid-19 cases after it received the Indian drug regulator''s approval. It will be available under the brand name FabiFlu as a prescription-based medication for Rs 103 per tablet, with recommended dose of 1,800 mg twice a...